Bo Lin
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Parathyroid Disorders and Treatments
- Chronic Kidney Disease and Diabetes
Papers in
- Nephrology 13
- Renal Diseases and Glomerulopathies 6
- Parathyroid Disorders and Treatments 3
- Chronic Kidney Disease and Diabetes 2
- Surgery 5
- Thyroid and Parathyroid Surgery 2
- Co-authors
- Qiang He (13 shared papers)Yiwen Li (7 shared papers)Juan Jin (5 shared papers)Ying‐Yu Ma (1 shared paper)Juan Jin (6 shared papers)Yingfan Hu (4 shared papers)Xiaogang Shen (3 shared papers)Jianguang Gong (3 shared papers)
- Journals
- Scientific Reports (4 papers)PLoS ONE (2 papers)Renal Failure (2 papers)Frontiers in Bioengineering and Biotechnology (1 paper)Journal of Fluorescence (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Bo Lin
31 papers receiving 256 citations
Peers
Comparison fields: 5 of 56
- Nephrology 85
- Clinical Biochemistry 10
- Molecular Medicine 7
- Pharmacology 21
- Transplantation 3
Countries citing papers authored by Bo Lin
This map shows the geographic impact of Bo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Lin more than expected).
Fields of papers citing papers by Bo Lin
This network shows the impact of papers produced by Bo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Lin. The network helps show where Bo Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 28 | |
| 2 | 2023 | 23 | |
| 3 | 2022 | 20 | |
| 4 | 2017 | 17 | |
| 5 | 2022 | 15 | |
| 6 | 1998 | 15 | |
| 7 | 2023 | 14 | |
| 8 | 2022 | 14 | |
| 9 | 2017 | 13 | |
| 10 | 2016 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2022 | 12 | |
| 13 | 2024 | 12 | |
| 14 | 2019 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2017 | 6 | |
| 17 | 2023 | 4 | |
| 18 | 2012 | 4 | |
| 19 | 2018 | 4 | |
| 20 | 2021 | 3 |
About Bo Lin
Bo Lin is a scholar working on Nephrology, Surgery, Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 34 papers that have together received 261 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (6 papers), Bone health and treatments (3 papers), Parathyroid Disorders and Treatments (3 papers), Galectins and Cancer Biology (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Thyroid and Parathyroid Surgery (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Nephrology (85 citations), Clinical Biochemistry (10 citations), Molecular Medicine (7 citations), Pharmacology (21 citations) and Transplantation (3 citations). Bo Lin has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Qiang He, Yiwen Li, Juan Jin, Ying‐Yu Ma, Juan Jin, Yingfan Hu, Xiaogang Shen, Jianguang Gong, Chengzhong Peng and Xiang Li. Their work appears in journals such as Scientific Reports, PLoS ONE, Renal Failure, Frontiers in Bioengineering and Biotechnology and Journal of Fluorescence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.